Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters










Publication year range
1.
Dokl Biochem Biophys ; 502(1): 1-4, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34874527

ABSTRACT

SARS-CoV-2 is a new coronavirus that is the cause of COVID-19 pandemic. To enter the cell, the virus interacts via its surface S protein with angiotensin-converting enzyme 2 (ACE2), the main entry receptor on the cell membrane. Most of protective antibodies, including those induced by vaccinations, target the S protein, preventing its interaction with the ACE2 receptor. We have evaluated an alternative strategy for blocking the S-ACE2 interaction using new antipeptide antibodies to the N-terminus of the ACE2 molecule. These antibodies allow detection of human ACE2 in vitro and ex vivo.


Subject(s)
Angiotensin-Converting Enzyme 2/immunology , COVID-19 , Pandemics , Angiotensins/metabolism , Humans , Pandemics/prevention & control , Protein Binding , SARS-CoV-2 , Spike Glycoprotein, Coronavirus
2.
Methods Mol Biol ; 2248: 91-107, 2021.
Article in English | MEDLINE | ID: mdl-33185870

ABSTRACT

Systemic cytokine inhibition may be an effective therapeutic strategy for several autoimmune diseases. However, recent studies suggest that tissue or cell type-specific targeting of certain cytokines, including TNF, may have distinct advantages and show fewer side effects. Here we describe protocols for generating and testing bispecific cytokine inhibitors using variable domain of single-chain antibodies from Camelidae (VHH) with a focus on cell-specific TNF inhibitors.


Subject(s)
Immunoglobulin Heavy Chains , Immunoglobulin Variable Region , Single-Domain Antibodies/biosynthesis , Tumor Necrosis Factor Inhibitors , Antibody Affinity , Antibody Specificity , Cytokines/biosynthesis , Flow Cytometry , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Single-Domain Antibodies/chemistry , Single-Domain Antibodies/isolation & purification , Single-Domain Antibodies/pharmacology , Tumor Necrosis Factor Inhibitors/chemistry , Tumor Necrosis Factor Inhibitors/isolation & purification , Tumor Necrosis Factor Inhibitors/pharmacology , Tumor Necrosis Factors/chemistry , Tumor Necrosis Factors/metabolism
3.
Cytokine Growth Factor Rev ; 53: 13-24, 2020 06.
Article in English | MEDLINE | ID: mdl-32475759

ABSTRACT

COVID-19 mortality is strongly associated with the development of severe pneumonia and acute respiratory distress syndrome with the worst outcome resulting in cytokine release syndrome and multiorgan failure. It is becoming critically important to identify at the early stage of the infection those patients who are prone to develop the most adverse effects. Elevated systemic interleukin-6 levels in patients with COVID-19 are considered as a relevant parameter in predicting most severe course of disease and the need for intensive care. This review discusses the mechanisms by which IL-6 may possibly contribute to disease exacerbation and the potential of therapeutic approaches based on anti-IL-6 biologics.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Coronavirus Infections/drug therapy , Cytokine Release Syndrome/drug therapy , Interleukin-6/antagonists & inhibitors , Pneumonia, Viral/drug therapy , Betacoronavirus/drug effects , Betacoronavirus/immunology , Betacoronavirus/pathogenicity , COVID-19 , Coronavirus Infections/mortality , Coronavirus Infections/pathology , Cytokine Release Syndrome/pathology , Cytokine Release Syndrome/virology , Humans , Interleukin-6/blood , Interleukin-6/immunology , Lung Diseases/immunology , Lung Diseases/pathology , Lung Diseases/virology , Pandemics , Pneumonia, Viral/mortality , Pneumonia, Viral/pathology , SARS-CoV-2
4.
Mol Biol (Mosk) ; 53(5): 741-754, 2019.
Article in Russian | MEDLINE | ID: mdl-31661475

ABSTRACT

Skin wound healing is subject to an intricate regulation, involves many cell populations and molecular mediators, and is one of the key mechanisms that ensures the barrier functions of the skin and the maintenance of body homeostasis. The efficiency of this process is largely determined by the balance of proinflammatory and proregenerative signals, which are mediated by cytokines. The review summarizes the latest data on the role of proinflammatory cytokines, mainly tumor necrosis factor (TNF), interleukin 6 (IL-6), interleukin 1 (IL-1), and interferons (IFNs), in skin wound healing, including those obtained with the use of genome editing techniques and methods of reverse genetics to establish relevant animal models. The roles that proinflammatory cytokines play at various stages of skin regeneration are discussed for both normal state and systemic pathologies, such as diabetes. Promising approaches to treating poorly healing wounds are summarized.


Subject(s)
Cytokines , Inflammation Mediators , Skin , Wound Healing , Animals , Interleukin-1 , Interleukin-6 , Mice , Tumor Necrosis Factor-alpha
5.
Mol Biol (Mosk) ; 53(5): 755-773, 2019.
Article in Russian | MEDLINE | ID: mdl-31661476

ABSTRACT

Dysregulated proinflammatory cytokine expression may result in the development of severe pathologies, such as rheumatoid arthritis, psoriasis, and neurodegenerative diseases. Transgenic mice and, in particular, those with controllable systemic overexpression of proinflammatory cytokines have recently become an essential instrument to study the molecular mechanisms underlying disease development. Importantly, many of the models are humanized by introducing a human cytokine gene, while leaving or removing the respective endogenous mouse gene. Humanized mice are especially valuable for biomedical research as they provide a relevant model to develop therapies based on blocking the pathogenic activity of a cytokine or to establish the functional significance of genome polymorphisms. The review discusses the available humanized mouse models with overexpression of key proinflammatory cytokines (TNF, IL-ip, and IL-6) and inflammatory cytokines with more specific functions (IL-8, IL-17, and IL-32) and their significance for basic and clinical research.


Subject(s)
Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Inflammation Mediators/metabolism , Up-Regulation , Animals , Arthritis, Rheumatoid/genetics , Cytokines/biosynthesis , Humans , Mice , Mice, Transgenic , Neurodegenerative Diseases/genetics , Psoriasis/genetics
6.
Mol Biol (Mosk) ; 53(5): 790-798, 2019.
Article in Russian | MEDLINE | ID: mdl-31661478

ABSTRACT

Recently, much attention has been drawn to unraveling the mechanisms of neurodegenerative and neuroinflammatory disease pathogenesis. A special role in the development of neuropathologies is assigned to the interaction of the nervous and the immune systems. Microglia are the cells of the immune system that function as resident macrophages of the central nervous system (CNS) and are involved in the development of CNS, as well as in homeostatic interactions. Impaired microglia can contribute to neuroinflammation and neurodegeneration. With the help of genome editing technologies, the main paradigms in the development and functions of microglia have been addressed. At the same time, an understanding of the mechanisms of regulation of microglia in normal and pathological conditions is necessary to create an effective therapy aimed at treating various neurological diseases. This review focuses on recent findings on the origin of microglia, its regulatory role in the central nervous system, as well as its contribution to the development of neuroinflammation.


Subject(s)
Central Nervous System/cytology , Central Nervous System/physiology , Homeostasis , Inflammation/pathology , Microglia/physiology , Neurodegenerative Diseases/pathology , Central Nervous System/pathology , Central Nervous System/physiopathology , Humans , Inflammation/physiopathology , Microglia/cytology , Microglia/pathology , Neurodegenerative Diseases/physiopathology
7.
Biochemistry (Mosc) ; 83(9): 1089-1103, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30472948

ABSTRACT

Cytokines play a pivotal role in maintaining homeostasis of the immune system and in regulation of the immune response. Cytokine dysregulation is often associated with development of various pathological conditions, including autoimmunity. Recent studies have provided insights into the cytokine signaling pathways that are involved not only in pathogenesis of autoimmune neuroinflammatory disorders, such as multiple sclerosis, but also in neurodegenerative states, for example, Alzheimer's disease. Understanding the exact molecular mechanisms of disease pathogenesis and evaluation of relevant experimental animal models are necessary for development of effective therapeutic approaches.


Subject(s)
Cytokines/metabolism , Encephalomyelitis, Autoimmune, Experimental/pathology , Animals , Antibodies, Monoclonal/therapeutic use , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Humans , Multiple Sclerosis/drug therapy , Multiple Sclerosis/immunology , Multiple Sclerosis/pathology , Neurodegenerative Diseases/immunology , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Neurons/metabolism , Signal Transduction , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/metabolism
8.
Dokl Biochem Biophys ; 483(1): 344-347, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30607736

ABSTRACT

To model human interleukin-6 (hIL-6) associated diseases, unique mice with transgenic overexpression of human IL-6 and reporter fluorescent protein EGFP in cells of macrophage-monocyte lineage were generated using loxP-Cre system. High level of hIL-6 production by macrophages and monocytes, as confirmed in vitro in primary culture of bone marrow-derived macrophages, in vivo resulted in early postnatal death in vivo, presumably, due to the effect of overexpression of hIL-6 on hematopoiesis.


Subject(s)
Hematopoiesis , Interleukin-6 , Macrophages/metabolism , Monocytes/metabolism , Animals , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Humans , Interleukin-6/biosynthesis , Interleukin-6/genetics , Macrophages/cytology , Mice , Mice, Transgenic , Monocytes/cytology
9.
Mol Biol (Mosk) ; 52(6): 963-974, 2018.
Article in Russian | MEDLINE | ID: mdl-30633239

ABSTRACT

Reverse genetics approach, involving genome editing, makes it possible not only to establish the nonredundant and unique functions of genes and their products, but also to construct animal models for biomedical research. Interleukin 6 (IL-6) is an important immunoregulatory and proinflammatory cytokine that differs from many related proteins in having a rather complicated signal transduction scheme. Apart from the multiple functions of IL-6, the most relevant biological problem of recent years was establishing what cells produce IL-6, in what form IL-6 is produced, what cells are recipients of the IL-6 signal, and what are the downstream events and physiological consequences of the IL-6 signaling cascade. Because IL-6 is involved in the pathogenesis of many diseases and is a drug target, understanding the mechanisms of its normal and pathogenic effects is important for the clinics. The review summarizes the recent data available in the field.


Subject(s)
Interleukin-6/metabolism , Reverse Genetics , Signal Transduction , Animals , Humans , Interleukin-6/genetics
10.
Acta Naturae ; 9(3): 89-93, 2017.
Article in English | MEDLINE | ID: mdl-29104780

ABSTRACT

Culturing of allogeneic or autologous cells in three-dimensional bioresorbable scaffolds is an important step in the engineering of constructs for regenerative medicine, as well as for experimental systems to study the mechanisms of cell differentiation and cell-to-cell interaction. Artificial substrates can modulate the phenotype and functional activity of immobilized cells. Investigating these changes is important for understanding the fundamental processes underlying cellular interactions in a 3D microenvironment and for improving tissue-engineered structures. In this study, we investigated the expression of the ICAM-1 adhesion molecule in mouse embryonic fibroblasts (MEF) when cultured on gelatin-fibroin scaffolds. Increased expression of ICAM-1 in MEF was detected only under 3D culture conditions both at the mRNA and protein levels. At the same time, the MEF cultured on various substrates did not oerexpress MAdCAM-1, indicating the selective effect of 3D culture conditions on ICAM-1 expression. One possible mechanism for ICAM-1 induction in MEF is associated with the activation of AP-1, since expression of c-Fos and Junb (but not cJun and Jund) was increased in MEF in 3D. When cultured under 2D conditions, the expression level of AP-1 components did not change.

11.
Biochemistry (Mosc) ; 81(11): 1251-1260, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27914451

ABSTRACT

The process of tissue regeneration following damage takes place with direct participation of the immune system. The use of biomaterials as scaffolds to facilitate healing of skin wounds is a new and interesting area of regenerative medicine and biomedical research. In many ways, the regenerative potential of biological material is related to its ability to modulate the inflammatory response. At the same time, all foreign materials, once implanted into a living tissue, to varying degree cause an immune reaction. The modern approach to the development of bioengineered structures for applications in regenerative medicine should be directed toward using the properties of the inflammatory response that improve healing, but do not lead to negative chronic manifestations. In this work, we studied the effect of microcarriers comprised of either fibroin or fibroin supplemented with gelatin on the dynamics of the healing, as well as inflammation, during regeneration of deep skin wounds in mice. We found that subcutaneous administration of microcarriers to the wound area resulted in uniform contraction of the wounds in mice in our experimental model, and microcarrier particles induced the infiltration of immune cells. This was associated with increased expression of proinflammatory cytokines TNF, IL-6, IL-1ß, and chemokines CXCL1 and CXCL2, which contributed to full functional recovery of the injured area and the absence of fibrosis as compared to the control group.


Subject(s)
Fibroins/pharmacology , Skin/immunology , Wound Healing/drug effects , Wound Healing/immunology , Wounds and Injuries/drug therapy , Wounds and Injuries/immunology , Animals , Cytokines/immunology , Female , Mice , Skin/pathology , Wounds and Injuries/pathology
12.
Biochemistry (Mosc) ; 81(11): 1274-1283, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27914453

ABSTRACT

Myeloid-derived suppressor cells represent a heterogeneous population of immature myeloid cells. Under normal conditions, these cells differentiate into macrophages, dendritic cells, and granulocytes. However, in pathological states such as inflammation, infection, or tumor growth, there is an arrest of their differentiation that results in the accumulation of immature myeloid cells in the organism. In addition, these cells acquire a suppressor phenotype, expressing anti-inflammatory cytokines and reactive oxygen and nitrogen species, and suppress T-cell immune response. Myeloid-derived suppressor cells (MDSC) contribute to cancerogenesis by forming a favorable microenvironment for tumor growth. Proinflammatory cytokines, secreted by tumor cells and the tumor microenvironment, induce angiogenesis and metastasis and promote tumor growth. They also provide signals necessary for survival, accumulation, and function of MDSC. Understanding the mechanisms of myeloid suppressor cell development and the use of proinflammatory cytokine inhibitors may prove beneficial for tumor therapy.


Subject(s)
Cell- and Tissue-Based Therapy/methods , Cytokines/immunology , Myeloid Cells/immunology , Neoplasms/immunology , Neoplasms/therapy , Animals , Humans , Inflammation/immunology , Inflammation/pathology , Inflammation/therapy , Myeloid Cells/pathology , Neoplasms/pathology
13.
Biochemistry (Mosc) ; 81(11): 1303-1308, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27914456

ABSTRACT

Tumor necrosis factor (TNF) is a pleiotropic cytokine that regulates many important processes in the body. TNF production in a physiological state supports the structure of lymphoid organs and determines the development of lymphoid cells in hematopoiesis. However, chronic TNF overexpression leads to the development of various autoimmune disorders. Sites of TNF production in the naïve state remain unclear due to the lack of in vivo models. In the present study, we used TNF-2A-Kat reporter mice to monitor the expression of TNF in different tissues. Comparative analysis of tissue fluorescence in TNF-2A-Kat reporter mice and wild type mice revealed constitutive expression of TNF in the skin of naïve adult mice. In the skin of TNF-2A-Kat reporter mouse embryos, no statistically significant differences in the expression of TNF compared to wild type animals were observed. Furthermore, we established that local depletion of microflora with topical antibiotics leads to a reduction in the fluorescence signal. Thus, we assume that the skin microflora is responsible for the expression of TNF in the skin of mice.


Subject(s)
Gene Expression Regulation/immunology , Microbiota/immunology , Skin/immunology , Skin/microbiology , Tumor Necrosis Factor-alpha/immunology , Animals , Mice , Mice, Transgenic , Skin/metabolism , Tumor Necrosis Factor-alpha/biosynthesis
14.
Biochemistry (Mosc) ; 81(11): 1340-1349, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27914459

ABSTRACT

Acute diseases of the respiratory tract are often caused by viral pathogens and accompanying secondary bacterial infections. It is known that the development of such bacterial complications is caused mainly by a decreased infiltration with immune system cells and by suppressed inflammation in the lungs. There are significant advances in understanding the mechanisms of secondary infections, although many details remain unclear. This review summarizes current knowledge of the molecular and cellular changes in the host organism that can influence the course of bacterial coinfections in the respiratory tract.


Subject(s)
Bacterial Infections/immunology , Lung/immunology , Respiratory Tract Infections/immunology , Animals , Bacterial Infections/pathology , Humans , Lung/pathology , Respiratory Tract Infections/pathology
15.
Pharmacol Ther ; 168: 98-112, 2016 12.
Article in English | MEDLINE | ID: mdl-27613100

ABSTRACT

Relationship between inflammation and cancer is now well-established and represents a paradigm that our immune response does not necessarily serves solely to protect us from infections and cancer. Many specific mechanisms that link chronic inflammation to cancer promotion and metastasis have been uncovered in the recent years. Here we are focusing on the effects that tumors may exert on inflammatory cascades, tuning the immune system ability to cause tumor promotion or regression. In particular, we discuss the contributions of chemokines, cytokines and exosomes to the processes such as induction of inflammation and tumorigenesis. Overall, tumor-elicited inflammation is a key driver of tumor progression and an essential component of tumor microenvironment.


Subject(s)
Inflammation/pathology , Neoplasms/pathology , Tumor Microenvironment/immunology , Animals , Chemokines/metabolism , Cytokines/metabolism , Disease Progression , Exosomes/metabolism , Humans , Inflammation/immunology , Neoplasms/immunology
16.
Acta Naturae ; 8(2): 10-23, 2016.
Article in English | MEDLINE | ID: mdl-27437136

ABSTRACT

This review addresses the issue of bioengineering of artificial lymphoid organs.Progress in this field may help to better understand the nature of the structure-function relations that exist in immune organs. Artifical lymphoid organs may also be advantageous in the therapy or correction of immunodefficiencies, autoimmune diseases, and cancer. The structural organization, development, and function of lymphoid tissue are analyzed with a focus on the role of intercellular contacts and on the cytokine signaling pathways regulating these processes. We describe various polymeric materials, as scaffolds, for artificial tissue engineering. Finally, published studies in which artificial lymphoid organs were generated are reviewed and possible future directions in the field are discussed.

17.
Bull Exp Biol Med ; 160(4): 491-4, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26899838

ABSTRACT

We fabricated bioresorbable microcarriers from water solution of Bombyx mori silk fi broin. The microcarriers are 3D structures with intricate surface and pores allowing penetration of culture medium, gas exchange, and cell adhesion. Fibroin molecules form hydrophobic structures and normally have a negative charge, which stimulates migration, but inhibits cell adhesion and makes it less effective. In order to improve adhesion efficiency and velocity, gelatin (hydrophilic biopolymer with integrin-recognizing RGD sequence) was added to the microcarrier composition. The resultant bioresorbable microcarriers support adhesion and proliferation of 3T3 murine fibroblasts.


Subject(s)
Absorbable Implants , Biocompatible Materials/chemistry , Bombyx/metabolism , Fibroins/chemistry , Gelatin/chemistry , 3T3 Cells , Animals , Cell Adhesion/drug effects , Cell Line , Cell Proliferation/drug effects , Mice
18.
Dokl Biochem Biophys ; 471(1): 393-395, 2016 Nov.
Article in English | MEDLINE | ID: mdl-28058677

ABSTRACT

The combined effect of innate immunity receptors in viral-bacterial coinfections was studied in vitro using the primary culture of murine macrophages activated by different combinations of ligands of innate immunity receptors belonging to the family of Toll-like receptors. The activation of macrophages first with a viral ligand and then with a bacterial one significantly decreased the expression of proinflammatory cytokine genes. Such attenuation of immune responses may occur during the development of bacterial complications in viral infections.


Subject(s)
Cytokines/genetics , Macrophage Activation , Macrophages/immunology , Membrane Glycoproteins/immunology , Toll-Like Receptor 4/immunology , Toll-Like Receptor 7/immunology , Toll-Like Receptors/agonists , Toll-Like Receptors/metabolism , Aminoquinolines/pharmacology , Animals , Bacterial Infections/immunology , Bacterial Infections/metabolism , Bone Marrow , Cells, Cultured , Coinfection/immunology , Coinfection/metabolism , Disease Models, Animal , Imiquimod , Immunity, Innate , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Ligands , Lipopolysaccharides/immunology , Membrane Glycoproteins/agonists , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , RNA, Messenger/metabolism , Toll-Like Receptor 4/agonists , Toll-Like Receptor 4/metabolism , Toll-Like Receptor 7/agonists , Toll-Like Receptor 7/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , Virus Diseases/immunology , Virus Diseases/metabolism
19.
Mol Biol (Mosk) ; 49(6): 937-43, 2015.
Article in Russian | MEDLINE | ID: mdl-26710772

ABSTRACT

Interleukin-6 (IL-6)--one of the most important pro-inflammatory cytokines that has a broad spectrum of immunoregulatory properties. Molecular mechanisms of signal transduction of IL-6 and its receptor, which were previously established, have recently been supplemented with a concept of trans-signaling. Selective inhibition of this signaling cascade would allow to modulate the pathological effects of IL-6. Methods of reverse genetics have helped to establish the physiological functions of IL-6 in normal state and in various diseases, including neoplasias. Therapeutic inhibitors of IL-6 or its receptor are already used for the treatment of several autoimmune diseases, however, systemic inhibition inevitably also neutralizes the protective functions of this cytokine. It is expected that in the future systemic therapy will be replaced by more specific and effective approaches that take into account the peculiarities of molecular signaling pathways in target cells and differences in the function of IL-6, depending on the cell source.


Subject(s)
Interleukin-6/metabolism , Signal Transduction , Animals , Antibodies, Blocking/therapeutic use , Autoimmune Diseases/drug therapy , Humans , Interleukin-6/genetics , Neoplasms/drug therapy , Receptors, Interleukin-6/immunology , Receptors, Interleukin-6/metabolism
20.
Dokl Biochem Biophys ; 463: 232-5, 2015.
Article in English | MEDLINE | ID: mdl-26335819

ABSTRACT

Microcarriers generated from recombinant spidroin 1F9 are suitable for use as an injection material. The microcarriers were a heterogeneous mixture of microgel particles ranging from 50 to 300 µm in size with the predominance of particles of 50-150 µm. The surface of these microparticles had a complex topography and ensured efficient cultivation of primary and immortalized fibroblasts. Intradermal injections of microgel suspensions into the area of full-thickness skin wounds did not lead to the development of acute inflammation in mice; instead, they accelerated the recovery of skin tissue and stimulated neurogenesis and angiogenesis.


Subject(s)
Drug Carriers/chemistry , Fibroins/chemistry , Microspheres , Recombinant Proteins/chemistry , Regenerative Medicine/methods , 3T3 Cells , Animals , Female , Mice , Particle Size , Skin Physiological Phenomena , Wound Healing/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...